Cambridge SME bridging nanomaterial characterization with pilot-scale advanced manufacturing, 3D printing, and composite recycling across EU consortia.
Cambridge Nanomaterials Technology (CNT) is a Cambridge-based SME specializing in nanomaterial processing, characterization, and integration into advanced manufacturing applications. They provide expertise in nanocomposite formulation, surface characterization (AFM, nanoindentation), and pilot-scale production for sectors ranging from construction materials to biomedical scaffolds. Their practical contribution across projects centers on translating nanomaterial science into manufacturable products — including 3D-printed microfluidics, recycled carbon fibre composites, and perovskite solar cells on flexible substrates.
Core expertise demonstrated across NANOLEAP (construction nanocomposites), Oyster (nano-architected materials characterization), nanoMECommons (nanomechanics protocols), nTRACK (nanoparticle tracking), and GENESIS (MOF membranes).
Consistent involvement in M3DLoC (3D microfluidic MEMS), Repair3D (recycled plastic 3D printing), TRiAnkle (3D bioprinted scaffolds), and EPPN (pilot production facilities).
Repair3D focused on CFRP recycling and design-for-recycling, while Carbo4Power addressed hybrid multi-material composite architectures for wind energy.
APOLO project developed printed flexible perovskite solar cells for building-integrated PV applications.
nTRACK (stem cell therapy tracking with nanoparticles) and TRiAnkle (3D bioprinted scaffolds for ankle joint regeneration) show growing involvement in medical applications.
In their early H2020 period (2015–2018), CNT focused on fundamental nanomaterial characterization, nanocomposite processing for construction, and pilot production infrastructure — essentially building credibility as a nanomaterials specialist. From 2019 onward, their work shifted markedly toward application-driven themes: circular economy (CFRP recycling), energy (perovskite solar), digital marketplaces for materials data, and biomedical 3D bioprinting. This evolution shows a company moving from "we know nanomaterials" to "we apply nanomaterials to solve specific industrial and societal problems."
CNT is pivoting from pure materials science toward circular economy applications and biomedical 3D printing, making them increasingly relevant for green manufacturing and health-tech consortia.
CNT operates exclusively as a participant — they have never coordinated an H2020 project, which is typical for a specialist SME that contributes deep technical know-how without taking on project management overhead. With 148 unique partners across 20 countries in 12 projects, they connect broadly rather than repeatedly with the same groups, suggesting they are valued as a flexible technical contributor that different consortia seek out. Their average project funding of ~€162K is consistent with a focused work-package contributor role rather than a large-scope partner.
CNT has collaborated with 148 distinct partners across 20 countries, giving them one of the wider networks you'd expect from a small company. Their connections span Western and Southern Europe heavily, reflecting the typical geography of H2020 manufacturing and materials consortia.
CNT sits at a rare intersection: they combine deep nanomaterial characterization capabilities (AFM, nanoindentation, mechanical testing) with hands-on pilot production and 3D printing experience. For consortium builders, this means a single SME partner that can both analyze advanced materials at the nanoscale and help scale them toward manufacturing — a bridge between lab research and industrial application that many projects struggle to fill. Their Cambridge location also places them in one of Europe's densest innovation ecosystems for materials science.
